PE116099A1 - 5-(2-etil-2-h-tetrazol-5-il)-1-metil-1,2,3,6-tetrahidropiridina - Google Patents
5-(2-etil-2-h-tetrazol-5-il)-1-metil-1,2,3,6-tetrahidropiridinaInfo
- Publication number
- PE116099A1 PE116099A1 PE1998000563A PE00056398A PE116099A1 PE 116099 A1 PE116099 A1 PE 116099A1 PE 1998000563 A PE1998000563 A PE 1998000563A PE 00056398 A PE00056398 A PE 00056398A PE 116099 A1 PE116099 A1 PE 116099A1
- Authority
- PE
- Peru
- Prior art keywords
- tetrazole
- methyl
- piridyl
- tetrahydro
- disorder
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK78197 | 1997-07-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE116099A1 true PE116099A1 (es) | 1999-11-23 |
Family
ID=8097489
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1998000563A PE116099A1 (es) | 1997-07-01 | 1998-06-25 | 5-(2-etil-2-h-tetrazol-5-il)-1-metil-1,2,3,6-tetrahidropiridina |
Country Status (25)
| Country | Link |
|---|---|
| EP (1) | EP0994869A1 (zh) |
| JP (1) | JP2002507215A (zh) |
| KR (1) | KR20010014297A (zh) |
| CN (1) | CN1261361A (zh) |
| AR (1) | AR013096A1 (zh) |
| AU (1) | AU735751B2 (zh) |
| BG (1) | BG103933A (zh) |
| BR (1) | BR9810331A (zh) |
| CA (1) | CA2293324A1 (zh) |
| CO (1) | CO4940483A1 (zh) |
| EA (1) | EA200000081A1 (zh) |
| HU (1) | HUP0002876A2 (zh) |
| IL (1) | IL133093A0 (zh) |
| IS (1) | IS5278A (zh) |
| JO (1) | JO2031B1 (zh) |
| MA (1) | MA25138A1 (zh) |
| NO (1) | NO996580D0 (zh) |
| PE (1) | PE116099A1 (zh) |
| PL (1) | PL337184A1 (zh) |
| SK (1) | SK187399A3 (zh) |
| TN (1) | TNSN98120A1 (zh) |
| TR (1) | TR199903283T2 (zh) |
| UY (2) | UY25069A1 (zh) |
| WO (1) | WO1999001448A1 (zh) |
| ZA (1) | ZA985498B (zh) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8714789D0 (en) * | 1987-06-24 | 1987-07-29 | Lundbeck & Co As H | Heterocyclic compounds |
| WO1997017074A1 (en) * | 1995-11-06 | 1997-05-15 | H. Lundbeck A/S | Treatment of traumatic brain injury |
-
1998
- 1998-06-18 AR ARP980102925A patent/AR013096A1/es not_active Application Discontinuation
- 1998-06-24 ZA ZA985498A patent/ZA985498B/xx unknown
- 1998-06-25 PE PE1998000563A patent/PE116099A1/es not_active Application Discontinuation
- 1998-06-25 JO JO19982031A patent/JO2031B1/en active
- 1998-06-26 CO CO98036576A patent/CO4940483A1/es unknown
- 1998-06-29 UY UY25069A patent/UY25069A1/es not_active Application Discontinuation
- 1998-06-30 TN TNTNSN98120A patent/TNSN98120A1/fr unknown
- 1998-07-01 KR KR1019997012429A patent/KR20010014297A/ko not_active Application Discontinuation
- 1998-07-01 EA EA200000081A patent/EA200000081A1/ru unknown
- 1998-07-01 CN CN98806497A patent/CN1261361A/zh active Pending
- 1998-07-01 SK SK1873-99A patent/SK187399A3/sk unknown
- 1998-07-01 EP EP98930655A patent/EP0994869A1/en not_active Withdrawn
- 1998-07-01 JP JP50616699A patent/JP2002507215A/ja active Pending
- 1998-07-01 MA MA25155A patent/MA25138A1/fr unknown
- 1998-07-01 PL PL98337184A patent/PL337184A1/xx unknown
- 1998-07-01 AU AU81020/98A patent/AU735751B2/en not_active Ceased
- 1998-07-01 TR TR1999/03283T patent/TR199903283T2/xx unknown
- 1998-07-01 HU HU0002876A patent/HUP0002876A2/hu unknown
- 1998-07-01 BR BR9810331-8A patent/BR9810331A/pt not_active Application Discontinuation
- 1998-07-01 CA CA002293324A patent/CA2293324A1/en not_active Abandoned
- 1998-07-01 IL IL13309398A patent/IL133093A0/xx unknown
- 1998-07-01 WO PCT/DK1998/000294 patent/WO1999001448A1/en not_active Application Discontinuation
- 1998-09-10 UY UY25177A patent/UY25177A1/es not_active Application Discontinuation
-
1999
- 1999-11-30 IS IS5278A patent/IS5278A/is unknown
- 1999-11-30 BG BG103933A patent/BG103933A/xx unknown
- 1999-12-30 NO NO996580A patent/NO996580D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BR9810331A (pt) | 2000-09-05 |
| EP0994869A1 (en) | 2000-04-26 |
| CN1261361A (zh) | 2000-07-26 |
| UY25177A1 (es) | 2000-12-29 |
| MA25138A1 (fr) | 2001-04-02 |
| HUP0002876A2 (hu) | 2001-06-28 |
| IS5278A (is) | 1999-11-30 |
| AU735751B2 (en) | 2001-07-12 |
| EA200000081A1 (ru) | 2000-08-28 |
| PL337184A1 (en) | 2000-08-14 |
| KR20010014297A (ko) | 2001-02-26 |
| AU8102098A (en) | 1999-01-25 |
| SK187399A3 (en) | 2000-06-12 |
| IL133093A0 (en) | 2001-03-19 |
| NO996580L (no) | 1999-12-30 |
| TNSN98120A1 (fr) | 2005-03-15 |
| CA2293324A1 (en) | 1999-01-14 |
| ZA985498B (en) | 1999-01-20 |
| CO4940483A1 (es) | 2000-07-24 |
| AR013096A1 (es) | 2000-12-13 |
| WO1999001448A1 (en) | 1999-01-14 |
| JP2002507215A (ja) | 2002-03-05 |
| UY25069A1 (es) | 1998-12-21 |
| JO2031B1 (en) | 1999-05-15 |
| NO996580D0 (no) | 1999-12-30 |
| TR199903283T2 (xx) | 2000-06-21 |
| BG103933A (en) | 2000-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102827067B (zh) | β-内酰胺酶抑制剂 | |
| UA120592C2 (uk) | Заміщені бензофуранільні та бензоксазолільні сполуки та їхнє застосування | |
| HUP0001547A2 (hu) | Az S-omeprazol új formája | |
| NO20061050L (no) | 7-(4-Substituerte-3-Cyclopropylaminometyl-1-Pyrrolidin yl)Kinolon-karboksylsyrederivater | |
| PT969819E (pt) | Nova forma cristalina de omeprazole | |
| EA200501593A1 (ru) | Азабициклические производные в качестве антагонистов мускаринового рецептора | |
| PE103799A1 (es) | Procedimiento de purificacion de mesilato de alatrofloxacino | |
| PE116099A1 (es) | 5-(2-etil-2-h-tetrazol-5-il)-1-metil-1,2,3,6-tetrahidropiridina | |
| BR9913720A (pt) | Processo de purificação por cristalização ourecristalização de ácidos carboxìlicos | |
| ATE72438T1 (de) | 2-pyridyl-penem-verbindungen. | |
| SA01220565B1 (ar) | مثبطات انزيم نقل الفارنسيل | |
| RU95113598A (ru) | Диарил-5,6-конденсированные-гетероциклические кислоты, фармацевтическая композиция, способ защиты и способ лечения | |
| EP1313504A4 (en) | METHODS AND COMPOSITIONS FOR INHIBITING ANGIOGENESIS | |
| BRPI9807312B8 (pt) | derivados de (4-piperidinil)-1h-2-benzopirano úteis como agentes antipsicóticos, composição farmacêutica e processo para a preparação dos referidos derivados | |
| DK0632028T3 (da) | Optisk aktivt 2-nitroimidazolderivat, fremgangsmåde til fremstilling af samme og mellemprodukt til fremstilling af samme | |
| NO881163L (no) | Fremgangsmaate for oppnaaelse av opploeste salter og syrer fra andre tilgjengelige slike, ved hjelp av ioneutvekslingsharpikser. | |
| ES2183843T3 (es) | Compuestos triciclicos que tienen afinidad por el receptor 5-ht1a. | |
| Rumyantsev et al. | Commercial reprocessing of breakdown products of molybdenum concentrate by ion exchange methods | |
| UA45782A (uk) | Спосіб добування скандію | |
| TH7741A (th) | นิวคลีโอไซด์ใช้รักษาโรค | |
| TH45290B (th) | องค์ประกอบของอาลาโทรฟลอกซาซินที่ให้โดยทางที่ไม่ใช่ทางปาก |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application declared void or lapsed |